Media coverage
6Media coverage
Title Vigeo Therapeutics to Present New Phase 1/2 VT1021 Dose Escalation and Expansion Data at the Society for Immunotherapy of Cancer's 2020 Annual Meeting Media name/outlet BioSpace Country United States Date 11/10/20 Persons Devalingam Mahalingam Title Vigeo Therapeutics to Present New Phase 1/2 VT1021 Dose Escalation and Expansion Data at the Society for Immunotherapy of Cancer's 2020 Annual Meeting Media name/outlet PR Newswire Country United States Date 11/9/20 Persons Devalingam Mahalingam Title Vigeo Therapeutics to Present New Phase 1/2 VT1021 Dose Escalation and Expansion Data at the Society for Immunotherapy of Cancer's 2020 Annual Meeting Media name/outlet Morningstar.com Country United States Date 11/9/20 Persons Devalingam Mahalingam Title Vigeo Therapeutics to Present New Phase 1/2 VT1021 Dose Escalation and Expansion Data at the Society for Immunotherapy of Cancer's 2020 Annual Meeting Media name/outlet Yahoo! Finance Country United States Date 11/9/20 Persons Devalingam Mahalingam Title Vigeo Therapeutics to Present New Phase 1/2 VT1021 Dose Escalation and Expansion Data at the Society for Immunotherapy of Cancer's 2020 Annual Meeting Media name/outlet TickerTech.com Country United States Date 11/9/20 Persons Devalingam Mahalingam Title Vigeo Therapeutics to Present New Phase 1/2 VT1021 Dose Escalation and Expansion Data at the Society for Immunotherapy of Cancer's 2020 Annual Meeting Media name/outlet WFMZ-TV Online Country United States Date 11/9/20 Persons Devalingam Mahalingam